Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

2.

Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer

3.

For MDS-Related Anemia, Telomerase Inhibitor Approved.

4.

Report provides global picture of wide inequalities in care for women's cancers

5.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot